These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1522358)

  • 41. Longitudinal study on relapses of leprosy in Polynesian multibacillary patients on dapsone monotherapy between 1946 and 1970.
    Cartel JL; Boutin JP; Spiegel A; Plichart R; Roux JF
    Lepr Rev; 1991 Jun; 62(2):186-92. PubMed ID: 1870381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of relapse among non-lepromatous patients released from treatment after dapsone monotherapy.
    Pandian TD; Muliyil J; Vellut C
    Lepr Rev; 1991 Sep; 62(3):288-96. PubMed ID: 1795587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leprosy beyond MDT: study of follow-up of 100 released from treatment cases.
    Vara N; Agrawal M; Marfatia Y
    Indian J Lepr; 2010; 82(4):189-94. PubMed ID: 21434595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy.
    Pattyn SR; Husser JA; Baquillon G; Maiga M; Jamet P
    Lepr Rev; 1990 Jun; 61(2):151-6. PubMed ID: 2198414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. International open trial of uniform multidrug therapy regimen for leprosy patients: Findings & implications for national leprosy programmes.
    Manickam P; Mehendale SM; Nagaraju B; Katoch K; Jamesh A; Kutaiyan R; Jianping S; Mugudalabetta S; Jadhav V; Rajkumar P; Padma J; Kaliaperumal K; Pannikar V; Krishnamurthy P; Gupte MD
    Indian J Med Res; 2016 Oct; 144(4):525-535. PubMed ID: 28256460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relapse and deformity among 2177 leprosy patients released from treatment with MDT between 2005 and 2010 in South India: A retrospective cohort study.
    Prabu R; Manickam P; Mahalingam VN; Jayasree P; Selvaraj V; Mehendale SM
    Lepr Rev; 2015 Dec; 86(4):345-55. PubMed ID: 26964430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation and relapse in bacterio-negative cases of leprosy under sulphone therapy: a 4 1/2 years follow-up.
    Neelan PN
    Lepr India; 1976 Oct; 48(4 Suppl):661-7. PubMed ID: 1026801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical features of relapse after multidrug therapy for leprosy in China.
    Shen J; Yan L; Sun P
    Lepr Rev; 2015 Jun; 86(2):165-9. PubMed ID: 26502687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low rate of relapse after twelve-dose multidrug therapy for hansen's disease: A 20-year cohort study in a brazilian reference center.
    Nery JAC; Sales AM; Hacker MAVB; Moraes MO; Maia RC; Sarno EN; Illarramendi X
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009382. PubMed ID: 33939710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Description of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Moura RS; Penna GO; Cardoso LP; de Andrade Pontes MA; Cruz R; de Sá Gonçalves H; Fernandes Penna ML; de Araújo Stefani MM; Bührer-Sékula S
    Am J Trop Med Hyg; 2015 Jun; 92(6):1280-4. PubMed ID: 25940192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dapsone hypersensitivity syndrome among leprosy patients in China.
    Tian W; Shen J; Zhou M; Yan L; Zhang G
    Lepr Rev; 2012 Dec; 83(4):370-7. PubMed ID: 23614255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Revalidation of various clinical criteria for the classification of leprosy--a clinic-pathological study.
    Gupta R; Kar HK; Bharadwaj M
    Lepr Rev; 2012 Dec; 83(4):354-62. PubMed ID: 23614253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation of multidrug therapy in the ALERT Leprosy Programme in the Shoa Region of Ethiopia. First results with paucibacillary patients.
    Becx-Bleumink M
    Lepr Rev; 1986 Jun; 57(2):111-9. PubMed ID: 3747703
    [No Abstract]   [Full Text] [Related]  

  • 54. Regularity of dapsone intake by leprosy patients attending urban treatment centre.
    Naik SS; Ganapati R
    Lepr India; 1977 Apr; 49(2):207-15. PubMed ID: 909287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors influencing the level of dapsone in blood.
    Beiguelman B; Pinto W; El-Guindy MM; Krieger H
    Bull World Health Organ; 1974; 51(5):467-71. PubMed ID: 4549497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Childhood leprosy: a retrospective descriptive study from Government Medical College, Kozhikode, Kerala, India.
    Sasidharanpillai S; Binitha MP; Riyaz N; Ambooken B; Mariyath OK; George B; Janardhanan AK; Sherjeena PV
    Lepr Rev; 2014 Jun; 85(2):100-10. PubMed ID: 25255613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relapses after multidrug therapy for leprosy: a preliminary report of 22 cases in west Nepal.
    van Brakel W; Kist P; Noble S; O'Toole L
    Lepr Rev; 1989 Mar; 60(1):45-50. PubMed ID: 2725171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions.
    Van Brakel WH; de Soldenhoff R; McDougall AC
    Lepr Rev; 1992 Sep; 63(3):231-46. PubMed ID: 1343818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Guidelines for the treatment of Hansen's disease in Japan (third edition)].
    Goto M; Nogam R; Okano Y; Gidoh M; Yotsu R; Ishida Y; Kitajima S; Kai M; Ishii N; Ozaki M; Hatano K; ;
    Nihon Hansenbyo Gakkai Zasshi; 2013 Dec; 82(3):143-84. PubMed ID: 24579462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acedapsone in the prevention of leprosy: field trial in three high prevalence villages in Micronesia.
    Russell DA; Worth RM; Jano B; Fasal P; Shepard CC
    Am J Trop Med Hyg; 1979 May; 28(3):559-63. PubMed ID: 453449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.